Growth Metrics

Cardlytics (CDLX) Equity Ratio (2017 - 2025)

Cardlytics' Equity Ratio history spans 9 years, with the latest figure at 0.02 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 112.78% year-over-year to 0.02; the TTM value through Dec 2025 reached 0.02, down 112.78%, while the annual FY2025 figure was 0.02, 112.78% down from the prior year.
  • Equity Ratio reached 0.02 in Q4 2025 per CDLX's latest filing, down from 0.02 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.73 in Q1 2021 to a low of 0.02 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.35, with a median of 0.35 recorded in 2023.
  • Peak YoY movement for Equity Ratio: skyrocketed 46.91% in 2021, then tumbled 112.78% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.55 in 2021, then crashed by 43.99% to 0.31 in 2022, then decreased by 23.31% to 0.23 in 2023, then fell by 24.09% to 0.18 in 2024, then plummeted by 112.78% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Equity Ratio are 0.02 (Q4 2025), 0.02 (Q3 2025), and 0.16 (Q2 2025).